145 related articles for article (PubMed ID: 34182498)
1. Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis.
Garrido MM; Ribeiro RM; Krüger K; Pinheiro LC; Guimarães JT; Holdenrieder S
In Vivo; 2021; 35(4):2207-2212. PubMed ID: 34182498
[TBL] [Abstract][Full Text] [Related]
2. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
Wittwer C; Boeck S; Heinemann V; Haas M; Stieber P; Nagel D; Holdenrieder S
Int J Cancer; 2013 Dec; 133(11):2619-30. PubMed ID: 23729200
[TBL] [Abstract][Full Text] [Related]
3. [The Value of Serum HMGB1 and sRAGE in the Diagnosis, Efficacy Monitoring and Prognosis of Newly Diagnosed Multiple Myeloma].
Wang J; Zeng AM; Liang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):493-500. PubMed ID: 35395985
[TBL] [Abstract][Full Text] [Related]
4. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
Stoetzer OJ; Wittwer C; Lehner J; Fahmueller YN; Kohles N; Fersching DM; Leszinski G; Roessner J; Holdenrieder S
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S217-24. PubMed ID: 22620489
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies.
Schröder L; Rupp ABA; Gihr KME; Kobilay M; Domroese CM; Mallmann MR; Holdenrieder S
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894448
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
Tang KT; Hsieh TY; Chao YH; Lin MX; Chen YH; Chen DY; Lin CC
PLoS One; 2017; 12(5):e0178404. PubMed ID: 28558055
[TBL] [Abstract][Full Text] [Related]
7. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Stoetzer OJ; Fersching DM; Salat C; Steinkohl O; Gabka CJ; Hamann U; Braun M; Feller AM; Heinemann V; Siegele B; Nagel D; Holdenrieder S
Tumour Biol; 2013 Feb; 34(1):81-90. PubMed ID: 22983919
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.
Kocsis AK; Szabolcs A; Hofner P; Takács T; Farkas G; Boda K; Mándi Y
Pancreatology; 2009; 9(4):383-91. PubMed ID: 19451748
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
10. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.
Romero R; Chaiworapongsa T; Savasan ZA; Hussein Y; Dong Z; Kusanovic JP; Kim CJ; Hassan SS
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):558-67. PubMed ID: 22578261
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon.
Schoenfeld J; Roeh A; Holdenrieder S; von Korn P; Haller B; Krueger K; Falkai P; Halle M; Hasan A; Scherr J
Front Physiol; 2023; 14():1118127. PubMed ID: 36866178
[No Abstract] [Full Text] [Related]
12. Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels.
Bang S; Yu J; Chung JH; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS
Sci Rep; 2021 Nov; 11(1):21951. PubMed ID: 34753938
[TBL] [Abstract][Full Text] [Related]
13. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
14. [The clinical decision-making value of prostate specific antigen and its derived indicators in prostate imaging reporting and data system version 2 3 lesions].
Yang S; Zhang YY; Zhao WL; Wei CG; Chen T; Li MJ; Tan SX; Shen JK
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):997-1001. PubMed ID: 32294856
[No Abstract] [Full Text] [Related]
15. Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.
Souza AW; de Leeuw K; van Timmeren MM; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
PLoS One; 2014; 9(4):e96067. PubMed ID: 24776932
[TBL] [Abstract][Full Text] [Related]
16. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
Front Immunol; 2019; 10():460. PubMed ID: 30923525
[TBL] [Abstract][Full Text] [Related]
17. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study.
Zakiyanov O; Kriha V; Vachek J; Zima T; Tesar V; Kalousova M
BMC Nephrol; 2013 Nov; 14():245. PubMed ID: 24188108
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.
Kohles N; Nagel D; Jüngst D; Stieber P; Holdenrieder S
Tumour Biol; 2012 Dec; 33(6):2401-9. PubMed ID: 22965881
[TBL] [Abstract][Full Text] [Related]
19. The association between plasma HMGB1 and sRAGE and clinical outcome in intracerebral hemorrhage.
Lei C; Geng J; Zhong L
J Neuroimmunol; 2020 Aug; 345():577266. PubMed ID: 32470565
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
